Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Moore

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Medical Hypotheses|October 6, 2009
Accounting for chance in the calculus of autoimmune diseaseDaniel J Moore
Science Translational Medicine|January 20, 2017
ERAD-icating mutant insulin promotes functional insulin secretionDaniel J Moore
Science Translational Medicine|December 2, 2016
Grave effects of a specific immune therapyDaniel J Moore
Pediatric Transplantation|October 12, 2016
New onset diabetes mellitus after heart transplantation in children is a common but potentially modifiable burdenDaniel J Moore
Organogenesis|February 4, 2011
Can technological solutions for diabetes replace islet cell function?Justin M Gregory, Daniel J Moore
The Journal of Clinical Endocrinology and Metabolism|December 6, 2021
Letter to the Editor From Gregory and Moore: "Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study"Justin M Gregory, Daniel J Moore
Clinical Pediatrics|June 25, 2011
Autoimmune alternating hypo- and hyperthyroidism in childrenRevi P Mathew, Daniel J Moore
Annals of Internal Medicine|January 26, 2021
The Dual Burden of Type 1 Diabetes and COVID-19Justin M Gregory, Daniel J Moore
Diabetes|March 20, 2026
Response to From Systemic B-Cell Targeting to Local Immune Engineering in Islet TransplantationChristopher S Wilson, Daniel J Moore
Transplant International : Official Journal of the European Society for Organ Transplantation|June 15, 2006
Avenues for immunomodulation and graft protection by gene therapy in transplantationDaniel J Moore, James F Markmann, Shaoping Deng
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Medical Hypotheses|October 6, 2009
Accounting for chance in the calculus of autoimmune diseaseDaniel J Moore
Science Translational Medicine|January 20, 2017
ERAD-icating mutant insulin promotes functional insulin secretionDaniel J Moore
Science Translational Medicine|December 2, 2016
Grave effects of a specific immune therapyDaniel J Moore
Pediatric Transplantation|October 12, 2016
New onset diabetes mellitus after heart transplantation in children is a common but potentially modifiable burdenDaniel J Moore
Organogenesis|February 4, 2011
Can technological solutions for diabetes replace islet cell function?Justin M Gregory, Daniel J Moore
The Journal of Clinical Endocrinology and Metabolism|December 6, 2021
Letter to the Editor From Gregory and Moore: "Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study"Justin M Gregory, Daniel J Moore
Clinical Pediatrics|June 25, 2011
Autoimmune alternating hypo- and hyperthyroidism in childrenRevi P Mathew, Daniel J Moore
Annals of Internal Medicine|January 26, 2021
The Dual Burden of Type 1 Diabetes and COVID-19Justin M Gregory, Daniel J Moore
Diabetes|March 20, 2026
Response to From Systemic B-Cell Targeting to Local Immune Engineering in Islet TransplantationChristopher S Wilson, Daniel J Moore
Transplant International : Official Journal of the European Society for Organ Transplantation|June 15, 2006
Avenues for immunomodulation and graft protection by gene therapy in transplantationDaniel J Moore, James F Markmann, Shaoping Deng
Pageof 11